Johnson & Johnson Teams Up with Naomi Watts to Reveal Why an Eye Exam is the Ultimate Self-Care Move for Women Over 40

Rhea-AI Summary

Johnson & Johnson (NYSE: JNJ) partnered with Naomi Watts on Dec. 3, 2025 to promote eye exams as part of self-care for people over 40. A new global survey found 82% of Americans say clear vision supports confidence, yet 48% of those over 40 who think they need vision correction haven't seen an eye care professional in the past year. The release highlights presbyopia (begins ~age 40), cataracts, and that an annual eye exam can detect 270+ health conditions. The campaign urges routine comprehensive eye exams, modern corrective options, and talking to a doctor to preserve vision and independence.

News Market Reaction

-0.04%

1 alert

-0.04% News Effect

On the day this news was published, JNJ declined 0.04%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Anti-aging market size: $59.7 billion Confidence and vision: 80% Concern about wrinkles: 55% +5 more

8 metrics

Anti-aging market size $59.7 billion Global anti-aging industry referenced in survey

Confidence and vision 80% Americans agreeing clear vision is key to feeling confident and youthful

Concern about wrinkles 55% People concerned about wrinkles around their eyes

Presbyopia prevalence Over 1 billion people Global population affected by presbyopia

Conditions detectable More than 270 Health conditions an annual eye exam can reveal

Youthful confidence link 82% Americans saying clear vision is important to feel youthful and confident

Unmet correction need 48% Respondents over 40 who think they need correction but skipped eye exam last year

Vision vs appearance 56% Global respondents prioritizing clear vision over physical appearance

Market Reality Check

Price: $239.99 Vol: Volume 8,963,243 is sligh...

normal vol

$239.99 Last Close

Volume Volume 8,963,243 is slightly below the 20-day average of 9,843,677 (volume_relative 0.91). normal

Technical Price $210.01 is above the 200-day MA $170.85 and about 1.06% above the $207.81 52-week high.

Peers on Argus

JNJ gained 3.29% while key peers showed mixed, mostly small moves (e.g., ABBV -0...

JNJ gained 3.29% while key peers showed mixed, mostly small moves (e.g., ABBV -0.69%, NVO +0.66%), suggesting stock-specific strength rather than a broad sector move.

Historical Context

5 past events · Latest: Dec 09 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 09	Clinical trial data	Positive	-0.8%	Phase 3 MajesTEC-3 showed strong survival and response benefits in RRMM.
Dec 08	Conference participation	Neutral	-0.8%	Announcement of J.P. Morgan Healthcare Conference fireside chat and webcast.
Dec 05	Clinical trial data	Positive	-0.1%	Phase 2b SunRISe-1 data for INLEXZO showing high DFS and OS in NMIBC.
Dec 03	Awareness partnership	Positive	-0.0%	Naomi Watts partnership to promote eye exams and healthy aging vision care.
Nov 18	Regulatory approval	Positive	+0.2%	TREMFYA SC induction regimen approval for ulcerative colitis with strong Phase 3 data.

Pattern Detected

Recent news, including strong clinical and regulatory updates, often saw modest or slightly negative next-day moves, indicating a tendency toward subdued or contrarian price reactions.

Recent Company History

Over the last few months, Johnson & Johnson reported several positive milestones. On Nov 18, 2025, TREMFYA gained FDA approval for a new SC induction regimen in UC. Subsequent December updates highlighted promising oncology data and participation in a major healthcare conference. The Dec 3, 2025 Naomi Watts partnership focused on eye health awareness, complementing the company’s existing medical portfolio. Price reactions around these events were generally modest, with small gains and losses clustering within about one percentage point.

Market Pulse Summary

This announcement highlights a partnership with Naomi Watts to promote eye exams and vision care as ...

Analysis

This announcement highlights a partnership with Naomi Watts to promote eye exams and vision care as self-care for people over 40, supported by survey data such as 82% linking clear vision to confidence and 48% skipping exams despite needing correction. It reinforces Johnson & Johnson’s positioning in eye health rather than changing its financial outlook. Investors may watch how this campaign integrates with existing ophthalmology offerings and whether future disclosures quantify any commercial impact.

Key Terms

presbyopia, cataracts, multifocal contact lenses, intraocular lenses

4 terms

presbyopia medical

"Those common aging concerns can include vision conditions like presbyopia and cataracts."

Presbyopia is the gradual loss of the eye’s ability to focus on close objects as the lens stiffens with age, causing tasks like reading or using a phone to require holding things farther away or using glasses. It matters to investors because it drives steady demand for corrective products and treatments—such as reading glasses, contact lenses, surgical procedures and emerging drugs—much like an aging population consistently needs new or replacement consumer goods and services.

cataracts medical

"Those common aging concerns can include vision conditions like presbyopia and cataracts."

A cataract is a clouding of the eye’s natural lens that blurs vision, much like a fogged-up camera lens or window. For investors, cataracts matter because they are common with aging and drive predictable demand for surgeries, lenses, medical devices and related drugs and services, affecting revenue and growth prospects for healthcare providers, device makers and companies serving an older population.

multifocal contact lenses medical

"Explore modern solutions: From multifocal contact lenses for presbyopia to advanced intraocular lenses"

Multifocal contact lenses are soft or rigid lenses designed with different corrective powers in different zones so a wearer can see clearly at near, intermediate and far distances without switching glasses. Think of them like a camera lens with built-in multiple focus settings. For investors, they matter because they represent a recurring consumer medical product with pricing and adoption affected by comfort, regulatory review, distribution through eye-care providers, and product differentiation in a competitive vision-care market.

intraocular lenses medical

"From multifocal contact lenses for presbyopia to advanced intraocular lenses for cataracts."

Intraocular lenses are small, implantable lenses placed inside the eye to replace the eye’s natural lens, commonly used during cataract surgery or vision-correcting procedures. Think of them like swapping the lens in a camera to restore clarity; investors watch them because demand, pricing, regulatory approval and technological upgrades directly affect sales, clinical adoption and profit potential for medical device and eye‑care companies.

AI-generated analysis. Not financial advice.

 New survey reveals Americans overlook eye health—despite its impact on confidence, independence and early disease detection.

JACKSONVILLE, Fla., Dec. 3, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson, a global leader in eye health, has partnered with Academy Award–nominated actress, producer, and entrepreneur, Naomi Watts, to change the conversation about vision. Together, they'll encourage simple, practical steps—such as routine eye checks and reframing eye care as part of holistic healthy aging, so that it becomes an easy and empowering part of daily self-care.

As we age, our bodies change in countless ways—including our hormones.¹ This shift can have a profound impact on our vision, yet eye health is often left out of the wellness conversation as we age. Findings from a new global survey confirm that while 80% of Americans agree that clear vision is key to feeling confident and youthful, nearly half think they need vision correction but haven't seen an eye care professional in the past year. Additionally, despite the booming $59.7 billion anti-aging industry's focus on skin and cosmetic treatments,² respondents ranked skin as the lowest priority in addressing the realities of aging. On average people prioritize clear vision over outward appearance, but only moderately, with 55% stating they are concerned with wrinkles around their eyes.

Those common aging concerns can include vision conditions like presbyopia and cataracts.^3,6 Presbyopia typically begins around age 40 and affects over 1 billion people globally.⁴ The condition makes it harder to focus on close objects. While cataracts, the leading cause of preventable blindness worldwide,⁵ clouds the lens of the eye causing cloudy or blurry vision. Cataracts and presbyopia can both be detected through comprehensive eye exams.^3,6 In fact, an annual eye exam can reveal more than 270 health conditions – including diabetes, heart disease, and stroke risk – making it a cornerstone of preventive care and healthy aging.⁷

Naomi Watts: Championing women's health and vision awareness

"As we age and go through menopause, changes in our eyesight are common, yet eye health is still missing from the conversation," said Naomi Watts.* "Through my partnership with Johnson & Johnson, I want to encourage everyone to see eye health as an essential part of overall well-being. The more we talk about these changes openly, the more empowered we are to take control of how we age. Start today by taking the simple step of scheduling your annual eye exam—it's one of the easiest ways to protect your vision for the future." 

The collaboration builds on Watts' long-standing advocacy for women's health and her work as the founder of Stripes Beauty, a company she launched to empower women through science-backed products, education and community during perimenopause and menopause. Watts will help bring greater attention to the impact of hormonal changes during perimenopause and menopause and how these shifts can affect vision. Through this initiative, she aims to raise awareness of the connection between menopause, aging, and eye health, encouraging individuals to prioritize regular eye exams as part of a holistic approach to well-being and longevity.

Expert perspective: Eye exams enable confidence and independence

"Clear vision isn't a luxury, it's an enabler of human potential and a cornerstone of healthy aging," said optometrist, Dr. Charissa Lee, Head of Professional Affairs, Vision, Johnson & Johnson. "While people invest significantly in skincare and cosmetic treatments to look younger, they often overlook that proper vision correction can help maintain a more relaxed, youthful appearance. As an Eye Care Professional, I believe the comprehensive eye exam and proactive eye care can fundamentally help you feel and look your best as you age."

Key survey findings reveal missed opportunities for healthy aging:

• Confidence and vision: 82% of Americans agree that clear vision is important to feel youthful and confident.
• Preventative Care Gap: 48% of respondents over 40 think they need vision correction but haven't visited an eye care professional in the past year.
• Health connection: While 87% of people surveyed demonstrated high awareness of eye care options for aging beyond just glasses, only 70% knew that eye exams can uncover medical conditions or understood how common vision correction is after age 40.
• Appearance vs. vision: Globally, 56% of individuals surveyed stated that they prioritize clear vision over physical appearance. However, 55% of global respondents aged 40 to 70 expressed concerns regarding the appearance of wrinkles around the eyes.

Take action: Make eye exams part of your healthy aging routine

Johnson & Johnson encourages individuals over the age of 40 to make vision care a self-care priority.

• Schedule a comprehensive eye exam: Early detection is key to maintaining confidence and independence.
• Explore modern solutions: From multifocal contact lenses for presbyopia to advanced intraocular lenses for cataracts.
• Talk to a doctor: Don't wait for vision problems to impact your quality of life.

To find an eye care professional near you click here.

About Vision at Johnson & Johnson

Johnson & Johnson has a deep legacy in developing transformational new products that improve the health of patients' eyes. We have a bold ambition: Vision Made Possible – improving sight for more than 40 million people each year. Through cutting-edge innovation, expertise in material and optical science, and advanced technologies, we are revolutionizing the way people see and experience the world. Visit us at clearvisionforyou.com, follow @JNJVision on Twitter, Johnson & Johnson | Vision on LinkedIn, and @JNJVision on Facebook.

About Johnson & Johnson 

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more about our MedTech sector's global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at https://thenext.jnjmedtech.com. Follow us at @JNJMedTech and on LinkedIn.

About the study

These are the findings of an Ipsos survey conducted on behalf of Johnson & Johnson. Fieldwork was conducted between August 23 to September 10, 2024. A total of n=9,895 adults (7000 of whom are aged 40-70) in key markets (Brazil, China, Germany, Great Britain, Japan, South Korea, United States) participated in the survey.

Quotas and weighting were used to ensure the sample's composition reflects that of the population according to census parameters.

About Ipsos

Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing nearly 20,000 people.

Our passionately curious research professionals, analysts and scientists have built unique multi- specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 business solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.

"Game Changers" – our tagline – summarizes our ambition to help our 5,000 clients navigate with confidence our rapidly changing world.

Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120, Mid-60 indices, STOXX Europe 600 and is eligible for the Deferred Settlement Service (SRD).

www.ipsos.com

*Disclosure: This is a paid endorsement. Naomi Watts was compensated for this quote.

¹ How hormones can affect eyes and vision. American Academy of Ophthalmology. (2018, November 12). https://www.aao.org/eye-health/tips-prevention/how-hormones-can-affect-eyes-vision
² Anti-Aging Services – Global Strategic Business Report. Research and Markets. (n.d.). https://www.researchandmarkets.com/reports/5301879/anti-aging-services-global-strategic-business?utm_source=GNE&utm_medium=PressRelease&utm_code=vggngd&utm_campaign=2040739+-+Anti-Aging+Services+Industry+Eyes+%2492+Billion+Revenue+Opportunity+by+2030+-+Surge+in+Medical+Tourism+for+Cosmetic+Procedures+Drives+Demand+for+Specialized+Anti-Aging+Clinics&utm_exec=jocamspi
³ What is presbyopia?. American Academy of Ophthalmology. (2025, October 7). https://www.aao.org/eye-health/diseases/what-is-presbyopia
⁴ Munis, P., Kassalow, J., & Lorey, M. (2024). Presbyopia: addressing an urgent global need. Community eye health, 37(122), 10–11.
⁵ Javitt, J. C., Wang, F., & West, S. K. (1996). Blindness due to cataract: epidemiology and prevention. Annual review of public health, 17, 159–177. https://doi.org/10.1146/annurev.pu.17.050196.001111
⁶ What are cataracts?. American Academy of Ophthalmology. (2025a, June 27). https://www.aao.org/eye-health/diseases/what-are-cataracts
⁷ See the full picture of your health with an annual Comprehensive Eye Exam. AOA. (n.d.). https://www.aoa.org/healthy-eyes/caring-for-your-eyes/full-picture-of-eye-health

Media Contacts:
Michelle Parker
MParker5@its.jnj.com 

Erin Farley
Efarley1@its.jnj.com

Investor Contact:
investor-relations@its.jnj.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-teams-up-with-naomi-watts-to-reveal-why-an-eye-exam-is-the-ultimate-self-care-move-for-women-over-40-302631093.html

SOURCE Johnson & Johnson MedTech

FAQ

What did Johnson & Johnson announce about eye health on Dec. 3, 2025 (JNJ)?

Johnson & Johnson announced a partnership with Naomi Watts to encourage annual eye exams and raise awareness of vision changes after age 40.

What key survey results did Johnson & Johnson share about Americans' vision (JNJ)?

Survey results show 82% of Americans link clear vision to confidence and 48% over age 40 who think they need correction haven't had an eye exam in the past year.

How many health conditions can an annual eye exam reveal according to JNJ's announcement?

The announcement states a comprehensive annual eye exam can reveal more than 270 health conditions including diabetes and heart disease indicators.

What vision conditions did the JNJ announcement highlight for people over 40?

The announcement highlighted presbyopia, which typically begins around age 40, and cataracts as common age-related conditions detectable by eye exams.

What actions does Johnson & Johnson recommend for people over 40 (JNJ)?

They recommend scheduling a comprehensive eye exam, exploring modern correction options like multifocal contacts or intraocular lenses, and consulting an eye care professional.